A randomized controlled trial of two hepatitis A vaccine doses among adolescents with juvenile idiopathic arthritis and Crohn's disease on immunosuppressive therapy: a pilot study

J Travel Med. 2024 Jun 3;31(4):taae065. doi: 10.1093/jtm/taae065.

Authors

Racheal Githumbi¹, Susan Kuhn¹, Carla Osiowy², Jacqueline Day², Jennifer C C deBruyn¹, Marvin J Fritzler³, Nicole A Johnson¹, Otto Vanderkooi¹, Heinrike Schmeling¹

Affiliations

¹ Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
² National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
³ Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

PMID: 38652172
DOI: 10.1093/jtm/taae065

No abstract available

Publication types

Randomized Controlled Trial

MeSH terms

Adolescent
Arthritis, Juvenile* / drug therapy
Crohn Disease* / drug therapy
Female
Hepatitis A / prevention & control
Hepatitis A Vaccines* / administration & dosage
Humans
Immunosuppressive Agents* / administration & dosage
Male
Pilot Projects

Substances

Hepatitis A Vaccines
Immunosuppressive Agents